Advertisement
Screener

Biohaven Ltd. (BHVN) Preferred Shares

2.0 / 5 stars · 11/28 Roast Me

Biohaven Ltd. Preferred Shares: Authorized and Outstanding

The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.

  • 2026-06-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
  • 2026-03-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
  • 2025-12-31: Preferred Stock, Value, Issued $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
  • 2025-09-30: Preferred Stock, Value, Issued $0.00; Preferred Stock, No Par Value $0.00; Preferred Stock, Shares Authorized 10.00M shares; Preferred Stock, Shares Issued 0.00 shares.
Period endPreferred Stock, Value, IssuedPreferred Stock, No Par ValuePreferred Stock, Shares AuthorizedPreferred Stock, Shares IssuedPreferred Stock, Shares Outstanding
2026-06-30$0.00
10-Q · filed 2026-08-10
$0.00
10-Q · filed 2026-08-10
10.00M shares
10-Q · filed 2026-08-10
0.00 shares
10-Q · filed 2026-08-10
0.00 shares
10-Q · filed 2026-08-10
2026-03-31$0.00
10-Q · filed 2026-05-04
$0.00
10-Q · filed 2026-05-04
10.00M shares
10-Q · filed 2026-05-04
0.00 shares
10-Q · filed 2026-05-04
0.00 shares
10-Q · filed 2026-05-04
2025-12-31$0.00
10-Q · filed 2026-08-10
$0.00
10-Q · filed 2026-08-10
10.00M shares
10-Q · filed 2026-08-10
0.00 shares
10-Q · filed 2026-08-10
0.00 shares
10-Q · filed 2026-08-10
2025-09-30$0.00
10-Q · filed 2025-11-10
$0.00
10-Q · filed 2025-11-10
10.00M shares
10-Q · filed 2025-11-10
0.00 shares
10-Q · filed 2025-11-10
0.00 shares
10-Q · filed 2025-11-10
2025-06-30$0.00
10-Q · filed 2025-08-11
$0.00
10-Q · filed 2025-08-11
10.00M shares
10-Q · filed 2025-08-11
0.00 shares
10-Q · filed 2025-08-11
0.00 shares
10-Q · filed 2025-08-11
2025-03-31$0.00
10-Q · filed 2025-05-12
$0.00
10-Q · filed 2025-05-12
10.00M shares
10-Q · filed 2025-05-12
0.00 shares
10-Q · filed 2025-05-12
0.00 shares
10-Q · filed 2025-05-12
2024-12-31$0.00
10-K · filed 2026-03-02
$0.00
10-K · filed 2026-03-02
10.00M shares
10-K · filed 2026-03-02
0.00 shares
10-K · filed 2026-03-02
0.00 shares
10-K · filed 2026-03-02
2024-09-30$0.00
10-Q · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
10.00M shares
10-Q · filed 2024-11-12
0.00 shares
10-Q · filed 2024-11-12
0.00 shares
10-Q · filed 2024-11-12
2024-06-30$0.00
10-Q · filed 2024-08-09
$0.00
10-Q · filed 2024-08-09
10.00M shares
10-Q · filed 2024-08-09
0.00 shares
10-Q · filed 2024-08-09
0.00 shares
10-Q · filed 2024-08-09
2024-03-31$0.00
10-Q · filed 2024-05-09
$0.00
10-Q · filed 2024-05-09
10.00M shares
10-Q · filed 2024-05-09
0.00 shares
10-Q · filed 2024-05-09
0.00 shares
10-Q · filed 2024-05-09
2023-12-31$0.00
10-K · filed 2025-03-03
$0.00
10-K · filed 2025-03-03
10.00M shares
10-K · filed 2025-03-03
0.00 shares
10-K · filed 2025-03-03
0.00 shares
10-K · filed 2025-03-03
2023-09-30$0.00
10-Q · filed 2023-11-14
$0.00
10-Q · filed 2023-11-14
10.00M shares
10-Q · filed 2023-11-14
0.00 shares
10-Q · filed 2023-11-14
0.00 shares
10-Q · filed 2023-11-14
2023-06-30$0.00
10-Q · filed 2023-07-31
$0.00
10-Q · filed 2023-07-31
10.00M shares
10-Q · filed 2023-07-31
0.00 shares
10-Q · filed 2023-07-31
0.00 shares
10-Q · filed 2023-07-31
2023-03-31$0.00
10-Q · filed 2023-05-12
$0.00
10-Q · filed 2023-05-12
10.00M shares
10-Q · filed 2023-05-12
0.00 shares
10-Q · filed 2023-05-12
0.00 shares
10-Q · filed 2023-05-12
2022-12-31$0.00
10-K · filed 2024-02-29
$0.00
10-K · filed 2024-02-29
10.00M shares
10-K · filed 2024-02-29
0.00 shares
10-K · filed 2024-02-29
0.00 shares
10-K · filed 2024-02-29
2021-12-31$0.00
10-K · filed 2023-03-23
$0.00
10-K · filed 2023-03-23
10.00M shares
10-K · filed 2023-03-23
0.00 shares
10-K · filed 2023-03-23
0.00 shares
10-K · filed 2023-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Generate Biomedicines, Inc. (GENB)United States$2.052B
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55